2 terminated, 1 completed. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Terminated 2, Completed 1 |
Follow EF5: new trials by email Literature Review of EF5 trials Research Report on EF5
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer EF5, motexafin lutetium, pharmacological study - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Not applicable | Terminated | National Cancer Institute (NCI) | 30 | 2004-05-01 | 2013-01-16 |
| EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer EF5, immunohistochemistry staining method, biopsy - Cervical Cancer | Not applicable | Completed | Gynecologic Oncology Group | 2003-06-01 | 2013-06-24 | |
| EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer EF5, diagnostic laboratory biomarker analysis, pharmacological study - Stage I Adult Soft Tissue Sarcoma, Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity | Not applicable | Terminated | National Cancer Institute (NCI) | 120 | 2001-08-01 | 2013-01-16 |
Sarcoma (2) · Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Colonic Neoplasms (1) · Fallopian Tube Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Pancreatic Neoplasms (1) · Rectal Neoplasms (1) · Stomach Neoplasms (1) · Uterine Cervical Neoplasms (1)
National Cancer Institute (NCI) (2) · Gynecologic Oncology Group (1)
United States (3)
Stephen Michael Hahn (2) · Gillian M. Thomas, BSc, MD, FRCPC, FRCR (Hon) (1)
P01CA087971 (1)